Skip to main content
Log in

Immune responses to oral and IM administration of M2e-Hsp70 construct

  • Original Article
  • Published:
Veterinary Research Communications Aims and scope Submit manuscript

Abstract

The eukaryotic expression plasmid of M2e-Hsp70 is a candidate M2e-based DNA vaccine. In order to evaluate the immunization potential of this construct, Specific Pathogen Free chickens were immunized either intramuscularly or orally. Mutant Salmonella typhimurium was used as carrier for oral delivery of the M2e-Hsp70 construct. M2e-specific humoral and cellular responses were tested by ELISA and Lymphocyte Proliferation Assay, respectively. Our results indicate that both humoral and cellular immune responses are conferred against M2e-Hsp70 plasmid in either of the intramuscular or oral routes of administration; however, these responses are significantly higher in intramuscular injection in contrast to oral administration. When it comes to mass vaccination of commercial chicken flocks oral administration is preferred due to the ease of application as well as its capability of eliciting mucosal, humoral and cellular immune responses; so measurements should be taken to improve the immunization potency of our orally delivered DNA vaccine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Ameiss K, Ashraf S, Kong W, Pekosz A, Wu WH, Milich D, Billaud JN, Curtiss R (2010) Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype. Vaccine 28:6704–6713

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ashby D, Leduc I, Lauzon W, Lee BC, Singhal N, Cameron DW (2005) Attenuated Salmonella typhimurium SL3261 as a vaccine vector for recombinant antigen in rabbits. J Immunol Methods 299:153–164

    Article  CAS  PubMed  Google Scholar 

  • Ashraf S, Kong W, Wang SF, Yang JS, Curtiss R (2011) Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine. Vaccine 29:3990–4002

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Babapoor S, Neef T, Mittelholzer C, Girshick T, Garmendia A, Shang H, Khan MI, Burkhard P (2011) A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection. Influenza research and treatment 2011: Article ID 126794

  • Darji A, Zur Lage S, Garbe AI, Chakraborty T, Weiss S (2000) Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier. FEMS Immunol Med Microbiol 27:341–349

    Article  CAS  PubMed  Google Scholar 

  • Denis J, Acosta-Ramirez E, Zhao Y, Hamelin ME, Koukavica I, Baz M, Abed Y, Savard C, Pare C, Lopez Macias C, Boivin G, Leclerc D (2008) Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. Vaccine 26:3395–3403

    Article  CAS  PubMed  Google Scholar 

  • Donnelly JJ, Wahren B, Liu MA (2005) DNA vaccines: Progress and challenges. J Immunol 175:633–639

    Article  CAS  PubMed  Google Scholar 

  • Fagan PK, Walker MJ, Chin J, Eamens GJ, Djordjevic SP (2001) Oral immunization of swine with attenuated Salmonella typhimurium aroA SL3261 expressing a recombinant antigen of Mycoplasma hyopneumoniae (NrdF) primes the immune system for a NrdF specific secretory IgA response in the lungs. Microb Pathog 30:101–110

    Article  CAS  PubMed  Google Scholar 

  • Fiers W, De Filette M, El Bakkouri K, Schepens B, Roose K, Schotsaert M, Birkett A, Saelens X (2009) M2e-based universal influenza A vaccine. Vaccine 27:6280–6283

    Article  CAS  PubMed  Google Scholar 

  • Fioretti D, Iurescia S, Fazio VM, Rinaldi M (2010) DNA Vaccines: Developing New Strategies against Cancer. J Biomed Biotechnol 2010: Article ID 174378

  • Frace AM, Klimov AI, Rowe T, Black RA, Katz JM (1999) Modified M2 proteins produce heterotypic immunity against influenza A virus. Vaccine 17:2237–2244

    Article  CAS  PubMed  Google Scholar 

  • Gosling JP (2000) Immunoassays: A Practical Approach. Oxford University Press, London

    Google Scholar 

  • Guo Z, Wang H, Yang T, Wang X, Lu D, Li Y, Zhang Y (2010) Priming with a DNA vaccine and boosting with an inactivated vaccine enhance the immune response against infectious bronchitis virus. J Virol Methods 167:84–89

    Article  CAS  PubMed  Google Scholar 

  • Haygreen L, Davison F, Kaiser P (2005) DNA vaccines for poultry: the jump from theory to practice. Expert Rev Vaccines 4:51–62

    Article  CAS  PubMed  Google Scholar 

  • Hoiseth SK, Stocker BAD (1981) Aromatic-Dependent Salmonella-Typhimurium Are Non-Virulent and Effective as Live Vaccines. Nature 291:238–239

    Article  CAS  PubMed  Google Scholar 

  • Huang J, Xie Y, Zhang Q, Shen X, Ren D (2000) Immune responses of a recombined live Salmonella typhimurium SL3261 expressing a multi-epitope antigen of HCV. Acta Microbiol Sin 40:495–499

    CAS  Google Scholar 

  • Ionescu RM, Przysiecki CT, Liang X, Garsky VM, Fan J, Wang B, Troutman R, Rippeon Y, Flanagan E, Shiver J, Shi L (2006) Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier. J Pharm Sci 95:70–79

    Article  CAS  PubMed  Google Scholar 

  • Jazi MH, Dabaghian M, Tebianian M, Gharagozlou MJ, Ebrahimi SM (2012) In vivo electroporation enhances immunogenicity and protection against influenza A virus challenge of an M2e-HSP70c DNA vaccine. Virus Res 167:219–255

    Article  CAS  PubMed  Google Scholar 

  • Jiao ZY, Chen MH, Zhu SL, Li LG, Chen J, Hu PJ (2003) Establishment of an attenuated Salmonella typhimurium vaccine strain SL3261 expressing Hp-NAP gene. CHINESE J Cell Mol Immunol 19:335–337

    CAS  Google Scholar 

  • Jiao H, Pan Z, Yin Y, Geng S, Sun L, Jiao X (2011) Oral and nasal DNA vaccines delivered by attenuated Salmonella enterica serovar Typhimurium induce a protective immune response against infectious bronchitis in chickens. Clin Vaccine Immunol 18:1041–1045

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kong W, Wanda SY, Zhang X, Bollen W, Tinge SA, Roland KL, Curtiss R (2008) Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment. Proc Natl Acad Sci U S A 105:9361–9366

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kong W, Brovold M, Koeneman BA, Clark-Curtiss J, Curtiss R (2012) Turning self-destructing Salmonella into a universal DNA vaccine delivery platform. Proc Natl Acad Sci U S A 109:19414–19419

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Layton SL, Kapczynski DR, Higgins S, Higgins J, Wolfenden AD, Liljebjelke KA, Bottje WG, Swayne D, Berghman LR, Kwon YM, Hargis BM, Cole K (2009) Vaccination of chickens with recombinant Salmonella expressing M2e and CD154 epitopes increases protection and decreases viral shedding after low pathogenic avian influenza challenge. Poult Sci 88:2244–2252

    Article  CAS  PubMed  Google Scholar 

  • Liu MA (2003) DNA vaccines: a review. J Intern Med 253:402–410

    Article  CAS  PubMed  Google Scholar 

  • Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou WM, Fiers W (1999) A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 5:1157–1163

    Article  CAS  PubMed  Google Scholar 

  • Ning JF, Zhu W, Xu JP, Zheng CY, Meng XL (2009) Oral delivery of DNA vaccine encoding VP28 against white spot syndrome virus in crayfish by attenuated Salmonella typhimurium. Vaccine 27:1127–1135

    Article  CAS  PubMed  Google Scholar 

  • Paglia P, Medina E, Arioli I, Guzman CA, Colombo MP (1998) Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 92:3172–3176

    CAS  PubMed  Google Scholar 

  • Pan Z, Zhang X, Geng S, Cheng N, Sun L, Liu B, Huang J, Jiao X (2009) Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus. Vaccine 27:1018–1023

    Article  CAS  PubMed  Google Scholar 

  • Pan Z, Zhang X, Geng S, Fang Q, You M, Zhang L, Jiao X, Liu X (2010) Prime-boost immunization using a DNA vaccine delivered by attenuated Salmonella enterica serovar Typhimurium and a killed vaccine completely protects chickens from H5N1 highly pathogenic avian influenza virus. Clin Vaccine Immunol 17:518–523

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Slepushkin VA, Katz JM, Black RA, Gamble WC, Rota PA, Cox NJ (1995) Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine 13:1399–1402

    Article  CAS  PubMed  Google Scholar 

  • Trampuz A, Prabhu RM, Smith TF, Baddour LM (2004) Avian influenza: a new pandemic threat? Mayo Clin Proc 79:523–530

    Article  PubMed  Google Scholar 

  • Turley CB, Rupp RE, Johnson C, Taylor DN, Wolfson J, Tussey L, Kavita U, Stanberry L, Shaw A (2011) Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults. Vaccine 29:5145–5152

    Article  CAS  PubMed  Google Scholar 

  • Wang Y, Kelly CG, Singh M, McGowan EG, Carrara AS, Bergmeier LA, Lehner T (2002) Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. J Immunol 169:2422–2429

    Article  CAS  PubMed  Google Scholar 

  • Wang BZ, Gill HS, Kang SM, Wang L, Wang YC, Vassilieva EV, Compans RW (2012) Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand. Clin Vaccine Immunol 19:1119–1125

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Wu F, Huang JH, Yuan XY, Huang WS, Chen YH (2007) Characterization of immunity induced by M2e of influenza virus. Vaccine 25:8868–8873

    Article  CAS  PubMed  Google Scholar 

  • Wu F, Yuan XY, Huang WS, Chen YH (2009a) Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine. Vaccine 27:6095–6101

    Article  CAS  PubMed  Google Scholar 

  • Wu F, Yuan XY, Li J, Chen YH (2009b) The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine. Vaccine 27:4320–4324

    Article  CAS  PubMed  Google Scholar 

  • Zhao G, Du L, Xiao W, Sun S, Lin Y, Chen M, Kou Z, He Y, Lustigman S, Jiang S, Zheng BJ, Zhou Y (2010) Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant. Vaccine 28:7233–7240

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This project was financially supported by grant no. 7502015/6/16 supplied by University of Tehran.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Farzaneh Assadian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Assadian, F., Nikbakht, G., Niazi, S. et al. Immune responses to oral and IM administration of M2e-Hsp70 construct. Vet Res Commun 38, 157–163 (2014). https://doi.org/10.1007/s11259-014-9599-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11259-014-9599-9

Keywords

Navigation